Outpatient phase III centers on applying recovery to real-world living. At this stage, the goal shifts from basic skills to social adjustment, independent living, and active participation in the community, including work, school, transportation, and social activities. This focus on reintegration into everyday life is why the statement is true. It isn’t limited to Phase I (which is more about acute stabilization and initial functional gains), nor is it unspecified or false—the emphasis on community interaction and social functioning is a defining feature of Phase III in many rehabilitation models.

During PAMS treatment, the energy delivered should feel noticeable but comfortable. A mild hot or cold sensation is a normal, expected response, indicating the therapeutic energy is interacting with the tissues and promoting a gentle change in local blood flow without causing harm. This sensation should be within the patient’s tolerance and not painful. In contrast, severe sharp pain would suggest the intensity is too high or tissue irritation is occurring; ringing in the ears isn’t a typical outcome of this modality and could point to an issue with exposure or settings; numbness beyond tolerance signals nerve over-stimulation or potential nerve involvement. If any of those occur, the clinician should reassess the treatment parameters.

The main concept is that TENS reduces pain by modulating spinal pain signals through gate control. When TENS delivers sensory-level stimulation, it activates large-diameter A-beta fibers, which in turn excite inhibitory interneurons in the dorsal horn of the spinal cord. This dampens the transmission of pain signals carried by small-diameter A-delta and C fibers to the brain, lowering pain perception. This analgesia is temporary and depends on ongoing stimulation. Deep tissue heating, strong motor contractions, or a permanent nerve block are not how TENS produces relief.

Fluidotherapy uses warm air with circulating cellulose particles to gently heat, desensitize, and movement-limiting edema in the hand. A fundamental safety rule is to avoid this modality when there are open wounds in the treated area. The warm environment and particulate medium can compromise wound integrity, increase the risk of infection, and disrupt healing. This is why open wounds in the hand are treated as a contraindication. Chronic swelling without wounds isn’t a barrier to use; edema reduction is one of the goals of fluidotherapy and it can be beneficial. A recent skin infection that is not on the treated limb doesn’t automatically prevent use if the infection is elsewhere and the hand itself isn’t infected. The statement that all hand injuries are contraindicated is incorrect because many hand injuries can still benefit from this modality when there are no open wounds or active infection in the treated area.